8037.HKライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 15:12):

China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People's Republic of China and Hong Kong...

Stats
本日の出来高	80 000.00
平均出来高	168 437
時価総額	279.34M
EPS	HKD0 ( 2024-03-28 )
Last Dividend	HKD0.0100 ( 2023-05-19 )
Next Dividend	HKD0 ( N/A )
P/E	-2.90
ATR14	HKD0 (0.00%)

China Biotech Services 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

China Biotech Services 財務諸表

Annual	2023
収益:	HKD211.99M
総利益:	HKD34.32M (16.19 %)
EPS:	HKD-0.0991

FY	2023
収益:	HKD211.99M
総利益:	HKD34.32M (16.19 %)
EPS:	HKD-0.0991

FY	2022
収益:	HKD1.85B
総利益:	HKD1.10B (59.46 %)
EPS:	HKD0.730

FY	2021
収益:	HKD623.76M
総利益:	HKD358.02M (57.40 %)
EPS:	HKD0.0200

Financial Reports:

No articles found.

China Biotech Services Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.0100 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

China Biotech Services Dividend Information - No Dividend Player

Dividend Sustainability Score: 1.007 - low (50.00%) | Divividend Growth Potential Score: 2.93 - Decrease likely (41.31%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.395	2004-08-19
Last Dividend	HKD0.0100	2023-05-19
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	HKD0.405	--
Avg. Dividend % Per Year	0.00%	--
Score	0.81	--
Div. Sustainability Score	1.007
Div.Growth Potential Score	2.93
Div. Directional Score	1.971	--

Next Divdend (Est)
(2041-12-30)

HKD0 Estimate 2.53 %

Dividend Stability

0.20 Very Poor

Dividend Score

0.81

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
6117.HK	Ex Dividend Junior	2023-05-22	Sporadic	0.00%
1857.HK	Ex Dividend Junior	2023-08-23	Semi-Annually	0.00%
0881.HK	Ex Dividend Junior	2023-06-23	Annually	0.00%
0026.HK	Ex Dividend Junior	2023-10-03	Semi-Annually	0.00%
2669.HK	Ex Dividend Knight	2023-06-23	Semi-Annually	0.00%
1428.HK	Ex Dividend Knight	2023-08-23	Annually	0.00%
0518.HK	Ex Dividend Junior	2023-09-01	Sporadic	0.00%
6869.HK	Ex Dividend Junior	2023-07-04	Annually	0.00%
1977.HK	Ex Dividend Knight	2023-09-11	Semi-Annually	0.00%
1036.HK	Ex Dividend Junior	2023-06-21	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.535	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.186	1.200	-6.21	-7.45	[0 - 0.3]
returnOnEquityTTM	-0.198	1.500	-3.31	-4.97	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.638	0.800	6.81	5.45	[1 - 3]
quickRatioTTM	1.543	0.800	5.63	4.50	[0.8 - 2.5]
cashRatioTTM	1.297	1.500	3.90	5.85	[0.2 - 2]
debtRatioTTM	0.152	-1.500	7.47	-10.00	[0 - 0.6]
interestCoverageTTM	-34.51	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	0.200	2.00	9.93	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.200	2.00	9.90	10.00	[0 - 20]
debtEquityRatioTTM	0.217	-1.500	9.13	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.0995	1.000	-1.675	-1.675	[0.2 - 0.8]
operatingProfitMarginTTM	-0.796	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	1.918	1.000	0.455	0.455	[0.2 - 2]
assetTurnoverTTM	0.348	0.800	-1.015	-0.812	[0.5 - 2]
Total Score				1.007

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-2.26	1.000	-0.330	0	[1 - 100]
returnOnEquityTTM	-0.198	2.50	-2.13	-4.97	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.200	2.00	9.93	10.00	[0 - 30]
dividendYielPercentageTTM	3.45	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.200	2.00	9.93	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.836	1.000	10.00	0	[0.1 - 0.5]
Total Score				2.93

China Biotech Services

China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People's Republic of China and Hong Kong. The company operates through five segments: Immunotherapy, Pharmaceutical Products, Medical and Health Related Services, Securities, Insurance brokerage, and Others segments. It also engages in the research, development, manufacture, sale, and distribution of health related and pharmaceutical products; trading of securities; money lending business; provision of tumor immune cell therapy, immune cell storage, and health management services; and provision of coordination of healthcare providers services. In addition, the company markets and sells health supplements, slimming pills, Chinese medicines, and beauty products; trades in pharmaceutical intermediates; and offers insurance brokerage services. Further, it provides property investment and logistic services. The company was formerly known as Rui Kang Pharmaceutical Group Investments Limited and changed its name to China Biotech Services Holdings Limited in November 2017. China Biotech Services Holdings Limited was founded in 1996 and is headquartered in Causeway Bay, Hong Kong.